Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Tempur-Pedic Q1 Profit Rises, But Stock Plunges On Forecast

RELATED NEWS
Trade TPX now with 

Mattress maker Tempur-Pedic International Inc. (TPX: Quote), said Thursday its profit for the first quarter increased from a year ago, mainly on improved gross margins and an 18 percent sales growth driven by its North American and International segments.

Nevertheless, shares of Tempur-Pedic plunged over 11 percent in after-hours trade, as investors expected the mattress and pillow maker to lift its outlook for the full year, which is short of current Street estimates.

Tempur-Pedic's net sales increased 18 percent, helped by North American segment that grew 17 percent and international segment advancing 19 percent.

The company's mattress sales rose 18 percent globally, driven by a 15 percent increase in the North American segment and 26 percent improvement in the international segment. Pillow sales increased 20 percent globally, with North America advancing 22 percent and International segment rose 17 percent.

Tempur-Pedic's gross profit margin improved to 53.6 percent, when compared to 52.3 percent recorded a year ago, attributed mainly due to improved efficiencies in manufacturing and distribution and fixed cost leverage related to higher production volumes.

Operating profit margin was 22.4 percent, down from 23.1 percent in the first quarter of 2011, due mainly to the company's strategic investments to drive growth, including brand advertising.

The company's net income for the first quarter rose to $56.2 million from $48.3 million in the prior-year quarter. On a per share basis, earnings rose to $0.86 from $0.68 in the same quarter last year. First-quarter net income included a net benefit of $2 million from the resolution of foreign tax matters.

On average, fourteen analysts polled by Thomson Reuters expected earnings of $0.84 per share for the quarter. Analysts' estimates typically excludes one-time or special items.

Tempur-Pedic's net sales for the first quarter increased 18 percent to $384.4 million from $325.8 million in the year-ago first quarter. On a constant currency basis, net sales grew 19 percent. Twelve analysts had a consensus revenue estimate of $384.53 million shares for the quarter.

Looking ahead to the full year 2012, Tempur-Pedic confirmed its full year 2012 outlook with earnings still expected in the range of $3.80 to $3.95 per share and net sales in the range of $1.60 billion to $1.65 billion.

Fourteen analysts on consensus, currently expect the company to earn $3.97 per share for the year, with revenues of $1.66 billion.

Tempur-Pedic shares closed at $83.75, down $3.51 or 4.02%, on a volume of 3.65 million shares on the NYSE. In after-hours, the stock plunged $11.20 or 13.19%, to trade at $72.60.

Register
To receive FREE breaking news email alerts for Tempur Sealy International Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.